Fundraising FoxDublin · Seed–Series A · 8 people tracked
Also known as Fountain Healthcare
Find your way into Fountain Healthcare Partners
Sign up to see every warm intro you have to Fountain Healthcare Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fountain Healthcare Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Fountain Healthcare Partners invests risk capital in ambitious founders building life sciences companies across specialty pharma, biopharmaceuticals, medical devices, and diagnostics. Drawing on over 30 years of investment experience, the firm follows a focused strategy aimed at creating value for both investors and portfolio companies. It targets seed and early-stage opportunities in Europe and the United States, seeking companies with the potential for a significant exit within three to six years of initial investment. The firm typically leads or co-leads investment syndicates and is committed to responsible investing.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 17 of 42 portfolio companiesHealthtech ×12Biotech ×10Medical Devices ×8Digital Health ×3AI & Machine Learning ×2Hardware ×2Longevity ×2SaaS ×2
HQs:United States×10Germany×1Ireland×1
Investments · 42 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 12018 · 12016 · 12014 · 12013 · 17 dated
Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.
BiotechDigital HealthHealthtechLongevity
Philip JaniakinMarie-Laure OzouxinRégis OlivierinFrancesca C. LawsonMark KowalaEleonore Jouannyin
Co-investorsJeito CapitalKurma PartnersOrbiMedV-Bio VenturesOmnes CapitalInvivo Capital Partners+1 more
Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia.
BiotechHealthtech
Florent Gros(Chief Executive Officer and Founder)Stephan Oehen(Chief Operating Officer and Founder)inBrice Suire(Chief Financial Officer and Founder)Nigel Clark(Chief Business Officer)Jens Hasskarl(Chief Medical Officer)
Co-investorsHealthCap4see Ventures
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.
BiotechHealthtechMedical DevicesMalvern, US
Ronald Crystal(Founder and Advisor (Board Observer))Todd Rosengart(Founder; Board Observer)John Tucker(President and CEO)Albert Gianchetti(Executive Officer, Director)
BoardGlenn Batchelder(Director)inJames Cohen(Director)
Co-investorsLumira VenturesJeito CapitalLongwood FundSofinnova Ventures
Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsLongitude CapitalSignet Healthcare PartnersSofinnova Ventures
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersBGVForbionHTGFPMV+2 more
HealthtechHayward, US
GUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)
BoardELIZABETH ROCKETT(Director)WENDE HUTTON(Director)in
Co-investorsCota CapitalEmergent Medical Partners, LLPKaiser Permanente VenturesMission Bay Capital5AM VenturesCanaan Partners+2 more
BiotechChelsea, US
RICHARD BATYCKY(Executive Officer)GLENN BATCHELDER(Director)BRYAN STUART(Executive Officer)inMARK IWICKI(Executive Officer, Director)inMARTIN FREED(Executive Officer)in
BoardROB HOPFNER(Director)in
Co-investorsCanaan PartnersLongitude CapitalSofinnova VenturesBay City CapitalOrbiMedRA Capital
Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.
BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE
Hans Moebius(Co-founder and CMO, Head of Clinical Operations)inAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in
Co-investorsAndera PartnersCARMA FUNDGimvLBBW Venture Capital GmbHLifeArc VenturesModi Ventures
Mainstay provides an AI-powered platform that enables higher education institutions to engage students through proactive, personalized coaching and messaging.
AI & Machine LearningEdTechHR TechSaaSArlington, US
Andrew Magliozzi(Founder)inKirk Daulerio(Co-Founder, Vice President, Community)in
BoardKEVIN TALBOT(Director)
Co-investorsAlumni VenturesBisk VenturesEastward Capital PartnersFundersClubK Street CapitalMichelson 20MM Foundation+12 more
Irish company developing an advanced neurostimulation device.
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)inAntoine Papiernik(Director)in
Co-investorsIreland Strategic Investment FundSeventure PartnersSofinnova PartnersViking GlobalAlly Bridge GroupGilde Healthcare+1 more
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersBioStar CapitalDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health Ventures
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.
HardwareHealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesClaret Capital PartnersMVM Life Science PartnersSofinnova PartnersEnterprise IrelandEQT Life Sciences+1 more
Neuromod is a medical technology company that developed Lenire, an FDA-approved bimodal neuromodulation device for treating tinnitus.
HardwareHealthtechMedical Devices
Ross O'Neill(Founder)in
Co-investorsXB Ventures
Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsSofinnova Ventures
AbbVie is a pharmaceutical company that discovers and develops medicines, working with external innovation partners to conduct research.
BiotechHealthtech
Co-investorsArtis VenturesCowles VenturesNew Enterprise Associates (NEA)Western Technology InvestmentFidelity InvestmentsFounders Fund
Biotechnology company developing products for overactive bladder and irritable bowel syndrome.
BiotechMalvern, US
Douglas Gessl(Executive Officer)inJames Walker(Executive Officer, Director)in
BoardScott Morenstein(Director)David Hirsch(Director)James Bennethum(Director)Stephen Tullman(Director)
Co-investorsLongitude CapitalSamsara BioCapital
Vivasure Medical develops polymer-based vascular closure devices and delivery systems for structural heart and endovascular interventions.
BiotechHealthtechMedical DevicesGalway, IE
Co-investorsPanakes Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AcordaAda Health Partners with BayerArravascCalypso BiotechCappella MedCappella/ArraVascChronoDualyxErmiumErmium TherapeuticsGenableInflazomeInnocollInotremKaNDy TherapeuticsMadeleine TherapeuticsMitsuiventuresNerre TherapeuticsNeuraviNeuromodOpsonaPalyon MedicalPalyonmedicalSyndesi TherapeuticsTrino Therapeutics
Portfolio news
latest coverage across their companiesNeurent Medical · finance.yahoo.com · Feb 12, 2026
Frequently asked questions
- How many investments has Fountain Healthcare Partners made?
- Fountain Healthcare Partners has 42 tracked investments.
- What stage does Fountain Healthcare Partners invest at?
- Fountain Healthcare Partners invests at the Seed, Series A stages.
- What is Fountain Healthcare Partners's typical check size?
- Fountain Healthcare Partners typically writes checks of $10.8M – $16.2M.
- What sectors does Fountain Healthcare Partners focus on?
- Fountain Healthcare Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Fountain Healthcare Partners located?
- Fountain Healthcare Partners is headquartered in Dublin, IE.
- Does Fountain Healthcare Partners lead rounds?
- Yes, Fountain Healthcare Partners leads investment rounds.
- Who does Fountain Healthcare Partners co-invest with?
- Fountain Healthcare Partners most often shares deals with Andera Partners, Longitude Capital, Sofinnova Ventures, among 39 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.